SQUARE IMPRINT (Maxalt-MLT 10 mg)
Generic Name: rizatriptan
Pill imprint SQUARE IMPRINT has been identified as Maxalt-MLT 10 mg.
Maxalt-MLT is used in the treatment of migraine and belongs to the drug class antimigraine agents. Risk cannot be ruled out during pregnancy. Maxalt-MLT 10 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- SQUARE IMPRINT
- 10 mg
- 14.00 mm
- Prescription only
- Drug Class:
- Antimigraine agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Merck & Company Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
|NDC Code||Manufacturer / Repackager|
|49884-0581||Par Pharmaceutical, Inc.|
|54868-4499||Physicians Total Care Inc (repackager)|
|35356-0275||Lake Erie Medical and Surgical Supply (repackager)|
Note: Inactive ingredients may vary.
More about Maxalt-MLT (rizatriptan)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.